BARBOLINI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.767
EU - Europa 2.260
AS - Asia 2.146
SA - Sud America 341
AF - Africa 52
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 8.589
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.677
SG - Singapore 686
IT - Italia 669
CN - Cina 529
GB - Regno Unito 363
IE - Irlanda 316
VN - Vietnam 246
BR - Brasile 236
HK - Hong Kong 233
DE - Germania 185
SE - Svezia 149
FI - Finlandia 117
FR - Francia 111
RU - Federazione Russa 87
IN - India 67
ID - Indonesia 63
KR - Corea 52
CA - Canada 50
TR - Turchia 49
AR - Argentina 37
UA - Ucraina 37
JP - Giappone 35
NL - Olanda 29
BE - Belgio 28
BG - Bulgaria 25
BD - Bangladesh 24
MX - Messico 24
PL - Polonia 24
LT - Lituania 23
CO - Colombia 21
ES - Italia 20
MY - Malesia 19
TW - Taiwan 19
IQ - Iraq 18
CZ - Repubblica Ceca 14
VE - Venezuela 14
IR - Iran 13
AT - Austria 12
EC - Ecuador 12
SA - Arabia Saudita 12
ZA - Sudafrica 12
AU - Australia 11
CL - Cile 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
MA - Marocco 9
PK - Pakistan 9
AL - Albania 8
UZ - Uzbekistan 8
EG - Egitto 6
KE - Kenya 6
NP - Nepal 6
TH - Thailandia 6
IL - Israele 5
MT - Malta 5
RO - Romania 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
JM - Giamaica 4
JO - Giordania 4
OM - Oman 4
PH - Filippine 4
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NO - Norvegia 3
PE - Perù 3
PT - Portogallo 3
PY - Paraguay 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
GA - Gabon 2
LV - Lettonia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
QA - Qatar 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
Totale 8.578
Salva come PNG Salva come JPEG
Città #
Ashburn 459
Singapore 437
Santa Clara 399
Dublin 314
Chandler 310
San Jose 234
Hong Kong 221
Fairfield 219
Southend 150
Dallas 149
Hefei 142
Beijing 117
Nyköping 112
Woodbridge 112
Helsinki 104
Ann Arbor 99
Seattle 95
London 92
Wilmington 89
Ho Chi Minh City 82
Houston 80
Council Bluffs 78
Modena 76
New York 75
Cambridge 72
Los Angeles 66
The Dalles 64
Hanoi 62
Dearborn 59
Seoul 51
Lauterbourg 45
Jakarta 44
Bologna 41
Milan 41
Munich 40
Jacksonville 38
Moscow 37
Fremont 34
Shanghai 34
São Paulo 30
Chicago 28
Rome 28
San Diego 28
Redwood City 27
Sofia 24
Princeton 23
Brussels 22
Orem 20
Frankfurt am Main 19
San Giuliano Milanese 19
Tokyo 19
Paris 18
Parma 18
Reggio Emilia 18
Bremen 17
Dong Ket 17
Warsaw 17
Eugene 15
Redondo Beach 15
Brooklyn 14
Falls Church 14
Mumbai 14
Portsmouth 14
Toronto 13
Buffalo 12
Columbus 12
Denver 11
Düsseldorf 11
Florence 11
Guangzhou 11
Haiphong 11
New Taipei 11
Izmir 10
Nuremberg 10
Phoenix 10
Chennai 9
Poplar 9
Salt Lake City 9
Baghdad 8
Brno 8
Caprarola 8
Cardiff 8
Da Nang 8
Genoa 8
Glasgow 8
Kent 8
Montreal 8
Stockholm 8
Tashkent 8
Istanbul 7
Johannesburg 7
Medellín 7
Melbourne 7
Mexico City 7
Norwalk 7
Santorso 7
Sassuolo 7
Shinjuku 7
Venezia 7
Amsterdam 6
Totale 5.775
Salva come PNG Salva come JPEG
Nome #
GD2 expression in breast cancer. 419
Interstitial Lung Disease in Abemaciclib-treated Patients during SARS-CoV-2 Pandemic: A Case Series. 374
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 373
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 373
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 352
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 343
Clinical Prognosticators in Patients Treated with CDK 4/6 Inhibitors for Hormone Receptors Positive Advanced Breast Cancer 343
A concise review of lenalidomide therapy for follicular lymphoma 338
The evolving role of microsatellite instability in colorectal cancer: A review 328
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 323
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 309
Endocrine-based targeted combination versus endocrine therapy alone as first-line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trials. 288
Breast Location for De Novo Extramedullary Myeloid Sarcoma 281
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 280
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 263
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis 263
Predictors of HER2 gene amplification in immunohistochemistry score 2+ Early Breast Cancer according to 2018 ASCO/CAP guidelines: a single institution analysis. 261
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 255
PROGNOSIS AND RESPONSE TO NEOADJUVANT CHEMOTHERAPY ACCORDING TO HER2 EXPRESSION IN EARLY BREAST CANCER: a retrospective single institution analysis 247
Combined endocrine approaches vs endocrine therapy alone as first line treatment in elderly patients with hormone receptor-positive, HER2 negative, advanced breast cancer: To prescribe for the patient or the physician? A meta-analysis of phase II and III randomized clinical trials 241
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients 237
Primary treatment strategy in elderly patients with hormone receptor positive early breast cancer: is breast cancer surgery. 233
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis 223
Adjuvant exemestane or tamoxifen plus ovarian suppression in premenopausal women: single institution analysis 222
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 202
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. 201
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer 201
LETTER TO THE EDITOR: Henoch-schönlein Purpura (HSP) in a Patient on Abemaciclib 198
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 180
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis 179
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis 150
Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2–positive early breast cancer: real–world data from NeoPowER study 137
Update on Pulmonary Toxicity Induced by New Breast Cancer Treatments. 30
Totale 8.647
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.437
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 35 48
2021/2022625 43 79 34 22 27 55 31 38 58 43 113 82
2022/20231.154 84 128 89 80 82 91 26 84 367 32 46 45
2023/2024648 31 35 62 65 61 57 78 62 35 36 64 62
2024/20251.718 58 35 61 119 325 239 131 108 188 106 140 208
2025/20263.146 238 98 317 331 447 219 528 198 359 363 48 0
Totale 8.647